在结核病治疗中的后冠状病毒疾病-疫苗接种免疫复合炎症综合征:一个病例报告
1The Oakridge School, 5900 Pioneer Pkwy, Arlington, TX, 76013, USA. agmehta06@gmail.com.
Journal of medical case reports
|March 3, 2025
概括
结核免疫复合炎症综合征 (IRIS) 是一种罕见的疾病. 一份病例报告表明,冠状病毒疾病 (COVID-19) 疫苗增剂可能在结核病患者中导致IRIS.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
背景情况:
- 结核病免疫复原炎症综合征 (IRIS) 是一种不常见的疾病,其结果是对Mycobacterium tuberculosis的过度活性免疫反应.
- 在免疫功能低下的个体中,特别是那些接受免疫抑制疗法 (如瘤缩因子抑制剂) 的个体中,可以发生IRIS.
研究的目的:
- 报告肺结核病例IRIS可能是由冠状病毒疾病 (COVID-19) 使者核糖核酸 (mRNA) 疫苗增剂引起的.
- 强调在结核病治疗期间出现矛盾症状恶化的患者考虑IRIS的重要性.
主要方法:
- 一个47岁的印度男子患有重新激活结核病的案例介绍.
- 在开始抗结核疗法和随后的COVID-19 mRNA疫苗增剂后监测症状.
- 基于临床评估和对高剂量类固醇治疗的反应来诊断IRIS.
主要成果:
- 患者经历了抗结核治疗的症状改善,随后在COVID-19 mRNA疫苗增剂后5天出现了严重的宪法症状.
- 该患者被诊断为免疫复合炎症综合征 (IRIS).
- 高剂量的类固醇治疗导致了成功的治疗和逐渐的断奶.
结论:
- 在抗结核治疗期间出现矛盾症状恶化的患者中,应考虑免疫复合炎症综合征 (IRIS),特别是在免疫复合期间.
- 过度活跃的免疫反应,可能由感染或mRNA疫苗助推剂引发,可能有助于IRIS的发展.
更多相关视频
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10.5K
15:57Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
12.2K
相关概念视频
Pulmonary Tuberculosis I
215
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
215
Pulmonary Tuberculosis V
163
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
163
Pulmonary Tuberculosis IV
128
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
128
Pulmonary Tuberculosis III
291
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
291
Pulmonary Tuberculosis II
208
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
208
Vaccinations
43.6K
Overview
43.6K
